PEPTIDE_CODEX

← All peptides

PC-011 · nootropic · selank

Selank

TP-7

Also: Selanc

Thr-Lys-Pro-Arg-Pro-Gly-Pro

human trialanimal study

A synthetic analogue of the immunomodulatory peptide tuftsin, developed at the Institute of Molecular Genetics in Russia. Selank has anxiolytic and nootropic properties, approved in Russia for treatment of anxiety and neurasthenia. It modulates mood without sedation or addiction potential.

Modulates GABA-A receptor expression, influences BDNF (brain-derived neurotrophic factor) levels, stabilizes enkephalins (endogenous opioid peptides) from enzymatic degradation, and modulates serotonin metabolism. Enhances IL-6 and affects the balance of T-helper cytokines.

  • Anxiety relief
  • Cognitive enhancement
  • Focus/concentration
  • Immune modulation
  • Mood stabilization
  • · Nasal irritation (intranasal)
  • · Fatigue (rare)

Mechanism of Action

Modulates GABA-A receptor expression, influences BDNF (brain-derived neurotrophic factor) levels, stabilizes enkephalins (endogenous opioid peptides) from enzymatic degradation, and modulates serotonin metabolism. Enhances IL-6 and affects the balance of T-helper cytokines.

Common Uses

Anxiety reliefCognitive enhancementFocus/concentrationImmune modulationMood stabilization

Dosage & Pharmacology

DOSAGE RANGE: 250-500 mcg 1-3x daily (intranasal)
HALF-LIFE: ~3-5 minutes (rapid enzymatic degradation, but CNS effects last hours)
MOL. WEIGHT: 751.9 Da
SEQUENCE:
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Dosage information is for research reference only. Not a recommendation.

Known Side Effects

  • Nasal irritation (intranasal)
  • Fatigue (rare)

Legal Status

US:Not FDA-approved, research chemical
UK:Not approved
EU:Not approved
RU:Approved medication

Related Peptides

View all Selank research on PubMed